Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTRN12615001304527Phase 2Completed
Phase 2, randomised, open-label trial in Cardiovascular Malformation (CVM) comparing Dexmedetomidine primary sedation with Midazolam usual practice control (2 arms). Primary endpoint: Feasibility of screening and recruitment. Started Apr 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ACTRN12615001304527.